Symposia at 2025 Midyear!
Don’t miss the ASHP Advantage Symposia at this year’s ASHP Midyear Clinical Meeting & Exhibition, where leading experts will provide engaging, in-person and virtual educational opportunities for attendees. Seating is limited and provided on a first-come, first-served basis.
If you are not attending the Midyear Clinical Meeting & Exhibition in person, register for the live webinars below.
Featured ASHP Advantage® Symposia at the ASHP Midyear!
Monday, Dec. 8
11:30 a.m. – 1 p.m. PT | 2:30 – 4 p.m. ET
And the Beat Goes On: Improving Heart Failure and Chronic Kidney Disease Outcomes with SGLT2 Inhibitors
This 1.5-hour educational activity will utilize patient cases to apply current guideline recommendations for early identification, screening, and treatment of patients with SGLT2 inhibitors in chronic kidney disease and heart failure.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Changing Therapeutic Landscape and the Role of the Pharmacist
This 1.5-hour educational activity discusses the pathophysiology of CIDP as well as the incidence, prevalence, clinical course, and burden of disease. A review of the current guideline-recommended therapies will be discussed, including any treatment limitations.
Checkpoint Well Taken: Identification and Management of Immune Related Adverse Events for Healthcare Practitioners
This 1.5-hour activity illustrates how to differentiate, recognize, and manage immune-related adverse events (irAEs) according to the most recent recommendations in national guidelines.
Pump Up Your Knowledge: IV Smart Pumps and the Vital Role of the Pharmacist
This 1.5-hour educational activity includes a discussion on current uses of IV smart infusion pumps, ways to manage alarms and alerts while optimizing patient safety, and strategies for optimization of this technology both at the bedside and behind the scenes.
Tuesday, Dec. 9
11:30 a.m. – 1 p.m. PT | 2:30 – 4 p.m. ET
Navigating the Complex Landscape of Pulmonary Arterial Hypertension: A Roadmap for Pharmacists
This 1.5-hour educational activity reviews the latest guidelines and recommended treatment options for Pulmonary Arterial Hypertension, including drug selection, combination therapies, safety and when and how to adjust and escalate treatment.
Hurry, Time is Wasting: The Pharmacy Workforce and the Cost-Effectiveness and Safety of Ready to Administer Products
This 1.5-hour educational activity reviews the evidence for the safety and cost-effectiveness of ready-to-administer (RTA) prefilled syringes compared to the traditional vial-and-syringe method, presents the latest study on pharmacy-related costs associated with IV push products, and discusses real-world aspects of transitioning from traditional to RTA products.
The Whole Kidney and Caboodle: Incorporating Guideline-Based Recommendations to Identify and Manage Chronic Kidney Disease and Reduce Cardiovascular Risks
This activity reviews the cardiovascular risks of CKD and discusses approaches to identify and screen patients at risk for CKD including real-world examples of best practices in interprofessional care and patient education to equip pharmacists to bridge gaps across the CKM spectrum.
Tagged for Success: Impactful Applications and Future Opportunities of RFID Technology
This 1.5-hour educational activity includes a discussion on current and unique uses of RFID technology, novel opportunities to support the use of RFID solutions, encouraging stakeholder buy-in, and future opportunities for RFID usage in healthcare.
Wednesday, Dec. 10
11:30 a.m. – 1 p.m. PT | 2:30 – 4 p.m. ET
The Whole Package: The Pharmacist’s Critical Role in Parenteral Nutrition and the Use of Multi-Chamber Bag Parenteral Nutrition
This 1.5-hour educational activity discusses appropriate patient selection for multi-chamber bag parenteral nutrition (MCB-PN) and how to safely prepare and dispense MCB-PN.
Finding Pneumo: Demystifying Pneumococcal Vaccine Evidence Recommendations
In this activity, experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.
Between a Rock and a Hard Plaque: The Relationship Between LDL-C and ASCVD Risk and Improving Patient Outcomes with PCSK9 Inhibitors
In this 1.5-hour interactive activity, pharmacists can learn how to better bridge the gap in ASCVD care with lipid screening, optimization of LDL-C lowering medication therapy, and improving medication adherence.